Darnell Clayborn

Darnell Clayborn is a seasoned legal professional with extensive experience in mergers and acquisitions, currently serving as Senior Counsel at AbbVie since July 2021, where Darnell advises on business development strategies related to pharmaceutical assets and emerging biotech startups. Previously held roles include Counsel at Katten Muchin Rosenman LLP and Associate at Dykema, where Darnell gained expertise in complex transactions and corporate counseling across various industries. Darnell holds a Doctor of Law (J.D.) from the University of Illinois College of Law, an MBA in Finance from the University of Pittsburgh Katz Graduate School of Business, and a Bachelor of Arts in Accounting and Finance from the University of Central Arkansas.